Please wait a minute...
J Zhejiang Univ (Med Sci)
    
Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes
YANG Lindong1, BAO Fang1,2, WU Yuanzhe1, SUN Lizhou3
1. Department of Obstetrics and Gynecology, General Hospital of PLA Eastern Theater Command, Nanjing 210002, China;
2. Department of Obstetrics and Gynecology, Jinling Hospital, Nanjing Medical University, Nanjing 210002, China;
3. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
Download: HTML (   PDF(531KB)
Export: BibTeX | EndNote (RIS)      

Abstract  Objective To investigate the relationship of group B streptococcus (GBS) colonization in late pregnancy with perinatal outcome. Methods Pregnant women who underwent antenatal check-up at Jinling Hospital and the Jiangsu Maternal and Child Health Hospital from January 2016 to February 2018 were enrolled in this study. The vaginal and rectal swab samples were collected for GBS culture at 35-37 weeks of pregnancy. The perinatal outcomes of positive and negative GBS groups were compared. The GBS-positive group samples were tested for antibiotic susceptibility. In GBS positive group the maternal and child perinatal outcomes were compared between pregnant women with antibiotics treatment and those without antibiotics. Results A total of 13,000 pregnant women were enrolled, and the overall colonization rate of GBS was 3.65% (475/13000). The colonization rate of GBS in the vagina was 2.33% (303/13000), and the colonization rate in the rectum was 1.75% (227/13000). Through the collection and detection of rectal specimens, the positive rate of GBS increased by 56.77% (172/303). The monthly colonization rate of GBS showed significant fluctuations with the highest in January and October (P<0.05). The sensitivity of 475 GBS-positive specimens to ceftriaxone, vancomycin and linezolid was 100%, and the sensitivity to ampicillin and penicillin was 97.26% and 93.47%, respectively. The resistance rates of levofloxacin, clindamycin, erythromycin and tetracycline were 30.11%, 48.00%, 52.21% and 88.63%. There was no significant difference in age, place of origin, place of residence, maternal history and BMI between GBS positive group and GBS negative group (P>0.05). The incidence of premature rupture of membranes, postpartum hemorrhage, puerperal infection, neonatal pneumonia and sepsis in GBS positive group was significantly higher than that in GBS negative group (P<0.01). In pregnant women with positive GBS, the incidence of puerperal infection, neonatal infection and admission to the NICU in the antibiotic group was significantly lower than that in the non-antibiotic group (P<0.05). Conclusion The total colonization rate of group B streptococci is low in the late pregnancy, and there is no significant seasonality. The detection of GBS can be significantly improved by supplementing rectal examination. Ceftriaxone, penicillin and ampicillin are currently the drugs of choice for the prevention and treatment of GBS-related diseases. GBS infection can increase the incidence of maternal and child complications. The use of antibiotics during labor can significantly improve the outcome of mothers and infants.

Key wordsPregnancy trimester, third      Streptococcus agalactiae      Anti-bacterial agents      Microbial sensitivity tests      Pregnancy outcome      Perinatology      Vagina/microbiology      Rectum/microbiology     
Received: 20 August 2019      Published: 16 April 2020
CLC:  R714.7  
Cite this article:

YANG Lindong, BAO Fang, WU Yuanzhe, SUN Lizhou. Relationship of group B streptococcus colonization in late pregnancy with perinatal outcomes. J Zhejiang Univ (Med Sci), 0, 0(0): 8-0.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2020.04.12     OR     http://www.zjujournals.com/med/Y0/V0/I0/8


晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析

目的:探讨妊娠晚期B群链球菌(GBS)定植情况、抗菌药物敏感性及妊娠结局。方法:纳入2016年1月至2018年12月在东部战区总医院和江苏省妇幼保健院建卡定期产检的孕妇,于孕35~37周采用标准方法采集阴道及直肠拭子进行GBS培养,并对阳性标本分离的菌株进行药物敏感性试验。按培养结果分为GBS阳性组和GBS阴性组,阳性组孕妇按照产程中是否使用了抗菌药物治疗分为用药组与未用药组,比较不同组别间妊娠结局的差异。结果:共13 000名孕妇入组,GBS总体定植率为3.65%(475/13 000)。GBS在阴道中定植率为2.33%(303/13 000),在直肠中定植率为1.75%(227/13 000)。通过对直肠标本的采集检测,GBS阳性检出率增加了56.77%(172/303)。GBS每月的定植率有明显波动,1月份和10月份最高(均P<0.05)。475份GBS阳性标本对头孢曲松、万古霉素和利奈唑胺的敏感率为100%,对氨苄西林和青霉素的敏感率分别为97.26%和93.47%,而对左氧氟沙星、克林霉素、红霉素、四环素的耐药率较高,分别为30.11%、48.00%、52.21%和88.63%。GBS阳性组胎膜早破、产后出血、产褥期感染、新生儿肺炎、败血症发生率较GBS阴性组明显增高(均P<0.01)。产程中预防性使用抗菌药物的GBS阳性孕妇产褥期感染、新生儿感染及入住NICU率明显低于未使用抗菌药物的孕妇(P<0.05或P<0.01)。结论:妊娠晚期总体B群链球菌定植率较低,无明显的季节性,通过补充直肠检测能提高GBS检出率。头孢曲松、青霉素和氨苄西林是目前预防和治疗GBS相关疾病的首选药物。GBS感染会明显增加母婴并发症的发生可能,产程中抗菌药物的使用能明显改善母婴的结局。

关键词: 妊娠末期,  无乳链球菌,  抗菌药,  微生物敏感性试验,  妊娠结局,  围生医学,  阴道/微生物学,  直肠/微生物学 
[1] EICKHOFF T C, KLEIN J O, DALY A K, et al. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci[J]. N Engl J Med, 1964,271:1221-1228. DOI:10.1056/NEJM196412102712401.
[2] LE DOARE K, HEATH P T. An overview of global GBS epidemiology[J]. Vaccine, 2013,31 Suppl 4:D7-D12. DOI:10.1016/j.vaccine.2013.01.009.
[3] EDMOND K M, KORTSALIOUDAKI C, SCOTT S, et al. Group B streptococcal disease in infants aged younger than 3 months:systematic review and meta-analysis[J]. Lancet, 2012,379(9815):547-556. DOI:10.1016/S0140-6736(11)61651-6.
[4] VERANI J R, MCGEE L, SCHRAG S J, et al. Prevention of perinatal group B streptococcal disease——revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010,59(RR-10):1-36.
[5] CHEN V L, AVCI F Y, KASPER D L. A maternal vaccine against group B Streptococcus:past, present, and future[J]. Vaccine, 2013,31 Suppl 4:D13-D19. DOI:10.1016/j.vaccine.2012.12.080.
[6] Clinical and Laboratory Standards Institute. M100-S22 Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement[S]. Wayne, PA:Clinical and Laboratory Standards Institute, 2012.
[7] JOHRI A K, LATA H, YADAV P, et al. Epidemiology of Group B Streptococcus in developing countries[J]. Vaccine, 2013,31 Suppl 4:D43-D45. DOI:10.1016/j.vaccine.2013.05.094.
[8] KWATRA G, CUNNINGTON M C, MERRALL E, et al. Prevalence of maternal colonisation with group B streptococcus:a systematic review and meta-analysis[J]. Lancet Infect Dis, 2016,16(9):1076-1084. DOI:10.1016/S1473-3099(16)30055-X.
[9] CHO C Y, TANG Y H, CHEN Y H, et al. Group B Streptococcal infection in neonates and colonization in pregnant women:An epidemiological retrospective analysis[J]. J Microbiol Immunol Infect, 2019,52(2):265-272. DOI:10.1016/j.jmii.2017.08.004.
[10] LU B, LI D, CUI Y, et al. Epidemiology of Group B streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiol Infect, 2014,20(6):O370-O373. DOI:10.1111/1469-0691.12416.
[11] JI W, ZHANG L, GUO Z, et al. Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China[J/OL]. PLoS One, 2017,12(8):e0183083. DOI:10.1371/journal.pone.0183083.
[12] 时春艳,曲首辉,杨磊, 等.妊娠晚期孕妇B族链球菌带菌状况的检测及带菌对妊娠结局的影响[J].中华妇产科杂志,2010,45(1):12-16. DOI:10.3760/cma.j.issn.0529-567x.2010.01.005. SHI Chunyan, QU Shouhui, YANG Lei, et al. Detection of maternal colonization of group B streptococcus in late pregnancy by real-time polymerase chain reaction and its effect on perinatal outcome[J].Chinese Journal of Obstetrics and Gynecology,2010,45(1):12-16. DOI:10.3760/cma.j.issn.0529-567x.2010.01.005. (in Chinese)
[13] RICK A M, AGUILAR A, CORTES R, et al. Group B streptococci colonization in pregnant guatemalan women:prevalence, risk factors, and vaginal microbiome[J]. Open Forum Infect Dis, 2017,4(1):ofx020. DOI:10.1093/ofid/ofx020.
[14] PHILIPSON E H, PALERMINO D A, ROBINSON A. Enhanced antenatal detection of group B streptococcus colonization[J]. Obstet Gynecol, 1995,85(3):437-439. DOI:10.1016/0029-7844(94)00412-7.
[15] KOVAVISARACH E, SA-ADYING W, KANJANAHAREUTAI S. Comparison of combined vaginal-anorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor[J]. J Med Assoc Thai, 2007,90(9):1710-1714.
[16] MA Y Y, HSU T Y, SHEN S Y, et al. Epidemiology of group B Streptococcus ST-17 clone in pregnant women of South Taiwan[J]. Gynecol Obstet Invest, 2012,73(4):285-293.DOI:10.1159/000334406.
[17] 林新祝,吴健宁,张雪芹, 等.晚孕期阴道B族链球菌定植与新生儿感染的关系[J].中华围产医学杂志,2016,19(7):491-496. DOI:10.3760/cma.j.issn.1007-9408.2016.07.003. LIN Xinzhu, WU Jianning, ZHANG Xueqin, et al. Relationship between group BStreptococcus colonization in late pregnancies and neonatal infection[J]. Chinese Journal of Perinatal Medicine, 2016, 19(7):491-496. DOI:10.3760/cma.j.issn.1007-9408.2016.07.003. (in Chinese)
[18] PHARES C R, LYNFIELD R, FARLEY M M, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005[J].JAMA, 2008, 299(17):2056-2065. DOI:10.1001/jama.299.17.2056.
[19] DE AZAVEDO J C, MCGAVIN M, DUNCAN C, et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada[J]. Antimicrob Agents Chemother, 2001,45(12):3504-3508. DOI:10.1128/AAC.45.12.3504-3508.2001.
[20] MORIKAWA Y, KITAZATO M, KATSUKAWA C, et al. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan[J]. J Infect Chemother, 2003,9(2):131-133. DOI:10.1007/s10156-002-0230-6.
[21] 沈铿, 马丁, 狄文,等. 妇产科学[M]. 3版, 北京:人民卫生出版社, 2015:164-166. SHEN Keng, MA Ding, DI Wen, et al. Obstetrics and Gynecology[M]. 3rd ed, Beijing:People's Medical Publishing House, 2015:164-166. (in Chinese)
[22] BARCAITE E, BARTUSEVICIUS A, TAMELIENE R, et al. Prevalence of maternal group B streptococcal colonisation in European countries[J]. Acta Obstet Gynecol Scand, 2008,87(3):260-271.DOI:10.1080/00016340801908759.
[23] GHADDAR N, ALFOUZAN W, ANASTASIADIS E, et al. Evaluation of chromogenic medium and direct latex agglutination test for detection of group B streptococcus in vaginal specimens from pregnant women in Lebanon and Kuwait[J]. J Med Microbiol, 2014,63(Pt 10):1395-1399.DOI:10.1099/jmm.0.066738-0.
[24] ARMISTEAD B, OLER E, ADAMS WALDORF K, et al. The double life of group B streptococcus:asymptomatic colonizer and potent pathogen[J]. J Mol Biol, 2019,431(16):2914-2931.DOI:10.1016/j.jmb.2019.01.035.
[25] BAKER C J. The spectrum of perinatal group B streptococcal disease[J]. Vaccine, 2013,31 Suppl 4:D3-D6.DOI:10.1016/j.vaccine.2013.02.030.
[26] GARVY B A, HARMSEN A G. The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice[J]. Inflammation, 1996,20(5):499-512.DOI:10.1007/bf01487042.
[27] STOLL B J, HANSEN N I, SÁNCHEZ P J, et al. Early onset neonatal sepsis:the burden of group B Streptococcal and E. coli disease continues[J]. Pediatrics, 2011,127(5):817-826.DOI:10.1542/peds.2010-2217.
[28] 邓江红,姚开虎,胡惠丽, 等.新生儿肺炎死亡病例中B族链球菌的检测[J].中华儿科杂志,2006,44(11):850-854. DOI:10.3760/j.issn:0578-1310.2006.11.015. DENG Jianghong, YAO Kaihu, HU Huili, et al. Detection of group B streptococcus in the cases died of neonatal pneumonia[J]. Chinese Journal of Pediatrics, 2006, 44(11):850-854. DOI:10.3760/j.issn:0578-1310.2006.11.015. (in Chinese)
[29] XU M, HU L, HUANG H, et al. Etiology and clinical features of full-term neonatal bacterial meningitis:a multicenter retrospective cohort study[J]. Front Pediatr, 2019,7:31. DOI:10.3389/fped.2019.00031.
[1] CHEN Xu,LI Yang,WANG Jinxi,CAI Hongliu,CAO Hongcui,SHENG Jifang. Pregnant women complicated with COVID-19: a clinical analysis of 3 cases[J]. J Zhejiang Univ (Med Sci), 2020, 49(2): 240-244.
[2] LIN Xiaoxiao,SUN Daifei,FU Jun,ZHONG Huizhen. Outcome of re-pregnancy in women with uterine artery embolization for postpartum hemorrhage[J]. J Zhejiang Univ (Med Sci), 2019, 48(5): 540-545.
[3] MEI Jin,LIU Jiao,WANG Min,ZHANG Wen,WANG Hao,LU Sha,HE Chaying,JIN Chunlei. Prenatal diagnosis and pregnancy outcomes of 22q11.2 duplication syndrome: analysis of 8 cases[J]. J Zhejiang Univ (Med Sci), 2019, 48(4): 429-433.
[4] SUN Ting,XU Mingjuan. Body weight and gestational outcomes in women with high normotension during pregnancy[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 174-179.
[5] SHI Jing,FENG Jue. New inhibitors targeting bacterial RNA polymerase[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 44-49.
[6] PENG Dandan,ZHOU Xudong. Parents' antibiotic use for children in Ningbo: knowledge, behaviors and influencing factors[J]. J Zhejiang Univ (Med Sci), 2018, 47(2): 156-162.
[7] LI Enshu, YE Xiaoqun, FANG Li, YE Yinghui. Effect of oxygen concentration on outcome of in-vitro fertilization-embryo transfer[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 290-294.
[8] SHI Biwei, CUI Long, YE Xiaoqun, YE Yinghui. Effects of embryo cryopreservation and thawing on clinical outcomes of transplantable embryos after cleavage-stage preimplantation genetic diagnosis or screening[J]. J Zhejiang Univ (Med Sci), 2017, 46(3): 295-299.
[9] ZHANG Jian-zhen, HE Jing. Risk factors of recurrent preeclampsia and its relation to maternal and offspring outcome[J]. J Zhejiang Univ (Med Sci), 2015, 44(3): 258-263.
[10] SHEN Qin-qin, ZHANG Tan. Research advances on prenatal maternal serum markers for screening adverse pregnancy outcomes[J]. J Zhejiang Univ (Med Sci), 2015, 44(3): 339-343.
[11] ZHANG Jie, LI Xiu-Juan. Biological characteristics of phage SM1 for Stenotrophomonas maltophilia and its effect in animal infection model[J]. J Zhejiang Univ (Med Sci), 2013, 42(3): 331-336.
[12] LI Miao, ZHU Yi-Min . Impact of hepatitis B virus on sperm parameters and outcome of assisted reproductive technology[J]. J Zhejiang Univ (Med Sci), 2013, 42(2): 237-241.
[13] . Serial recombinant expression and anti-tumor activity in vitro of antibiotic peptide Alloferon-1[J]. J Zhejiang Univ (Med Sci), 2011, 40(5): 501-507.